Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/1998
09/01/1998US5800991 Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics
09/01/1998US5800834 Liquisolid systems and methods of preparing same
09/01/1998US5800828 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
09/01/1998US5800807 Ophthalmic compositions including glycerin and propylene glycol
09/01/1998US5800685 Electrically conductive adhesive hydrogels
08/1998
08/28/1998CA2230805A1 Preservative for emulsion and emulsion containing same
08/28/1998CA2230485A1 Glycolipid derivatives and the use thereof
08/27/1998WO1998037200A2 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies
08/27/1998WO1998037111A1 Transdermal pressure sensitive adhesive drug delivery system and pressure sensitive adhesive used therein
08/27/1998WO1998037087A1 Inhibition of major groove dna binding proteins by modified polyamides
08/27/1998WO1998037067A1 Design, synthesis and use of specific polyamide dna-binding ligands
08/27/1998WO1998037066A1 Improved polyamides for binding in the minor groove of double stranded dna
08/27/1998WO1998037057A1 Preparation of acid amides and metallisation of compounds
08/27/1998WO1998036778A1 Sustained drug delivery and compositions useful therefor
08/27/1998WO1998036777A1 Site-specific drug delivery
08/27/1998WO1998036776A2 Gel delivery vehicles for anticellular proliferative agents
08/27/1998WO1998036748A1 Methods and compositions for the protection of mitochondria
08/27/1998WO1998036747A1 Pharmaceutical composition
08/27/1998WO1998036740A2 Transdermal or topical plaster system with a polyacrylate matrix with improved physical properties
08/27/1998WO1998036738A1 Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
08/27/1998WO1998036736A1 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation
08/27/1998WO1998036735A1 Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water
08/27/1998WO1998036733A2 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
08/27/1998WO1998022140A3 Hybrid compositions for intracellular targeting
08/27/1998WO1998022094A3 Method for producing shaped and unshaped polyol masses
08/27/1998WO1998013031A3 Medicinal aerosol formulations comprising budesonide
08/27/1998WO1998006437A3 Compositions and methods for polynucleotide delivery
08/27/1998DE19716905C1 Aqueous L-selegilin solution for treating Parkinson's disease
08/27/1998CA2615918A1 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies
08/27/1998CA2282501A1 Sustained drug delivery and compositions useful therefor
08/27/1998CA2281919A1 Gel delivery vehicles for anticellular proliferative agents
08/27/1998CA2281794A1 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies
08/27/1998CA2281493A1 Site-specific drug delivery
08/27/1998CA2276339A1 Transdermal pressure sensitive adhesive drug delivery system and pressure sensitive adhesive used therein
08/26/1998EP0860442A1 Oligosaccharide oxazolines, oligosaccharide conjugates and methods of preparation thereof
08/26/1998EP0860170A1 Isotopic urea tablets
08/26/1998EP0860169A2 Compositions for oral administration containing pyridazinone compounds
08/26/1998EP0859857A1 Cationic polyacrylates and poly(alkyl)acrylates or the corresponding acrylamides for use in synthetic transfection or blocking systems
08/26/1998EP0859804A1 Water-soluble or water-dispersible polyurethanes with terminal acid groups, the production and the use thereof
08/26/1998EP0859751A1 Semi-fluorinated alkanes and their use
08/26/1998EP0859636A1 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization
08/26/1998EP0859635A1 Stabilised pharmaceutical compositions containing dobutamine
08/26/1998EP0859634A1 Pharmaceutical compositions containing platelet aggregation inhibitors
08/26/1998EP0859628A1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
08/26/1998EP0859626A1 Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing the said preparation
08/26/1998EP0859624A1 GnRH/REDUCED PSEUDOMONAS EXOTOXIN CONJUGATES
08/26/1998EP0859612A2 Novel composition containing an acid-labile omeprazole and process for its preparation
08/26/1998EP0859603A1 Sustained release matrix for high-dose insoluble drugs
08/26/1998EP0859601A2 Prolonged release of gm-csf
08/26/1998EP0859600A1 New technology for wet granulation
08/26/1998EP0859599A1 Liposomal formulations of mitoxantrone
08/26/1998EP0859598A1 Liposomes containing a corticosteroid
08/26/1998EP0859597A1 Sustained release delivery system and long acting narcotic analgesics and antagonists
08/26/1998EP0859596A2 Gel formulations containing growth factors
08/26/1998EP0859595A1 Therapeutic preparation for the transdermal administration of active substances
08/26/1998EP0656015B1 New nimesulide salt cyclodextrin inclusion complexes
08/26/1998EP0653938B1 Topical composition
08/26/1998EP0563093B1 A composition used as a therapeutic agent against chronic viral hepatic diseases
08/26/1998CN1191545A Process of high purity albumin production
08/26/1998CN1191492A Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
08/26/1998CN1191475A Drug delivery compositions for improved stability of steroids
08/26/1998CN1191139A Liquid gonadotropin containing formulations
08/26/1998CN1191089A Method for preparing equa cyclodextrin clathrate
08/25/1998US5798491 Multi-mechanistic chemical cleavage using certain metal complexes
08/25/1998US5798342 Use of natural cyclodextrins and their derivatives for the solubilization of platelet anti-aggregating agents from the family of ginkgolides
08/25/1998US5798338 Steroid/beta-cyclodextrin clathrate; oxidation resistance
08/25/1998US5798227 Expressing the globulins in the same cell such that alpha and beta globulin-like polypeptides are assembled and combined with heme to produce a hemoglobin-like protein
08/25/1998US5798225 Process for recombinant production of PTH and PTHrp analogs
08/25/1998US5798115 Biocompatible polymer comprising an active drug on polymer backbone; biodegradable, releasing the drug
08/25/1998US5798113 Grafting a vehicle containing core which contains isolated cells, either suspended in liquid or immobilized within hydrogel matrix, surrounded by a biocompatible jacket which protects isolated cells in core from immunological attack
08/25/1998US5798102 Beta-amyloyd, streptolysin o, growth hormone
08/25/1998US5798097 Immunogobulin conjugates
08/25/1998US5798090 Enhancement of the cellular immune response
08/25/1998CA2137677C Stabilized somatotropin for parenteral administration
08/25/1998CA2122479C Risedronate delayed-release compositions
08/25/1998CA2121345C Lipophilic oligosaccharide antibiotic salt compositions
08/25/1998CA2117588C Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
08/25/1998CA2107620C Stable topical formulations with good active ingredient release characteristics, containing at least one lipophilized macrolide antibiotic
08/20/1998WO1998036074A2 Single and double chain antibodies to the egf receptor, derivates thereof and their use
08/20/1998WO1998036002A1 Cross-linked vinyl polymers with bile acid adsorbing effect
08/20/1998WO1998035993A1 Polysaccharide, micro-organism and method for obtaining same, composition containing it and application
08/20/1998WO1998035984A2 Compositions and methods for highly efficient transfection
08/20/1998WO1998035982A1 Compounds for use in adept
08/20/1998WO1998035828A1 Lamellar gels and methods for making and regulating
08/20/1998WO1998035709A1 Method and composition for coating wound or protecting animal skin
08/20/1998WO1998035707A1 Compositions that bind to pancreatic cancer cells and methods of using the same
08/20/1998WO1998035705A1 Use of heat shock proteins to deliver moieties into cells
08/20/1998WO1998035704A1 Targeted therapeutic delivery of vitamin d compounds
08/20/1998WO1998035703A2 Methods and compositions for delivery of therapeutic agents to bone tissue employing conjugates of negatively charged peptide oligomers with therapeutic agents
08/20/1998WO1998035702A1 Inhibition of gene transcription by polyamide dna-binding ligands
08/20/1998WO1998035701A1 Drug targeting
08/20/1998WO1998035700A1 Composition with base of coconut oil and its use
08/20/1998WO1998035694A2 A pharmaceutical composition for treating hepatitis b virus (hbv) infection
08/20/1998WO1998035688A1 Method for destroying retinal pigment epithelial cells
08/20/1998WO1998035679A1 Stabilization of naloxonhydrochlorid
08/20/1998WO1998035663A1 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound
08/20/1998WO1998035662A1 Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium
08/20/1998WO1998035660A1 Transdermal, oral and intravenous preparations of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone
08/20/1998WO1998035656A1 Process for preparing solid pharmaceutical dosage forms
08/20/1998WO1998035653A1 Implantable collagen-containing putty material
1 ... 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 ... 1712